Value of intensity-modulated radiotherapy in stage IV head-and-neck squamous cell carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 5, 2010, Pages 1373-1380

  Dirix, Piet ^a   Nuyts, Sandra ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Altered fractionation; Chemotherapy; Head and neck cancer; IMRT

Indexed keywords

ALTERED FRACTIONATION; CHEMORADIOTHERAPY; CISPLATINUM; FRACTIONATION SCHEDULES; HEAD-AND-NECK CANCER; HEAD-AND-NECK SQUAMOUS CELL CARCINOMA; IMRT; INTENSITY MODULATIONS; INTENSITY-MODULATED RADIOTHERAPY; LOCOREGIONAL CONTROL; OVERALL SURVIVAL; TOTAL DOSE; TREATMENT OUTCOMES; XEROSTOMIA;

CHEMOTHERAPY; HYBRID MATERIALS; PATIENT MONITORING; RADIOTHERAPY; TOXICITY;

PHYSICAL THERAPY;

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; COHORT ANALYSIS; DERMATITIS; DISEASE SEVERITY; DRUG WITHDRAWAL; DYSPHAGIA; FEMALE; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; MALE; MUCOSA INFLAMMATION; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SALIVARY GLAND DISEASE; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; ORGANS AT RISK; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; XEROSTOMIA;

EID: 77956664219     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.10.018     Document Type: Article

References (35)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. A. Argiris, M.V. Karamouzis, D. Raben, and R.L. Ferris Head and neck cancer Lancet 371 2008 1695 1709
3. J. Bourhis, J. Overgaard, and H. Audry Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis Lancet 368 2006 843-584
4. S. Nuyts, P. Dirix, and R. Hermans Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer Head Neck 29 2007 720 730
5. J.P. Pignon, J. Bourhis, and C. Domenge Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data Lancet 355 2000 949 955
6. J.P. Pignon, A. le Maître, and E. Maillard Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients Radiother Oncol 92 2009 4 14
7. W. Budach, T. Hehr, and V. Budach A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck BMC Cancer 6 2006 28
8. S. Nuyts, P. Dirix, and P. Clement Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head and neck squamous cell carcinoma Int J Radiat Oncol Biol Phys 73 2009 1088 1095
9. A. Trotti Toxicity in head and neck cancer: A review of trends and issues Int J Radiat Oncol Biol Phys 47 2000 1 12
10. M. Machtay, J. Moughan, and A. Trotti Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis J Clin Oncol 26 2008 3582 3589
11. L. Veldeman, I. Madani, and F. Hulstaert Evidence behind use of intensity-modulated radiotherapy: A systematic review of comparative clinical studies Lancet Oncol 9 2008 367 375
12. P. Dirix, S. Nuyts, and B. Vanstraelen Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses Radiother Oncol 85 2007 385 391
13. A. Maes, C. Weltens, and P. Flamen Preservation of parotid function with uncomplicated conformal radiotherapy Radiother Oncol 63 2002 203 211
14. American Joint Committee on Cancer Cancer staging manual 6th ed. 2002 Springer-Verlag New York
15. K.S.C. Chao, F.J. Wippold, and G. Ozyigit Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT Int J Radiat Oncol Biol Phys 53 2002 1174 1184
16. A. Eisbruch, R.L. Foote, and B. O'Sullivan Intensity-modulated radiation therapy for head and neck cancer: Emphasis on the selection and delineation of the targets Semin Radiat Oncol 12 2002 238 249
17. V. Grégoire, P. Levendag, and K.K. Ang CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines Radiother Oncol 69 2003 227 236
18. V. Grégoire, A. Eisbruch, M. Hamoir, and P. Levendag Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck Radiother Oncol 79 2006 15 20
19. P. Dirix, S. Abbeel, and B. Vanstraelen Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: Dose-effect relationships for the swallowing structures Int J Radiat Oncol Biol Phys 75 2009 385 392
20. Lambert L, Fortin B, Soulires D, et al. Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: Are we succeeding? Int J Radiat Oncol Biol Phys. In press.
21. M. Yao, K.J. Dornfeld, and J.M. Buatti Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma - The University of Iowa experience Int J Radiat Oncol Biol Phys 63 2005 410 421
22. F.F. de Arruda, D.R. Puri, and J. Zhung Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: The Memorial Sloan-Kettering Cancer Center experience Int J Radiat Oncol Biol Phys 64 2006 363 373
23. N.Y. Lee, F.F. de Arruda, and D.R. Puri A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma Int J Radiat Oncol Biol Phys 66 2006 966 974
24. N.Y. Lee, W. O'Meara, and K. Chan Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers Int J Radiat Oncol Biol Phys 69 2007 459 468
25. K. Huang, P. Xia, and C. Chuang Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: The University of California-San Francisco experience Cancer 113 2008 497 507
26. N.F. Saba, S. Edelman, and M. Tighiouart Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: A retrospective single-institution analysis Head Neck 31 2009 1447 1455
27. W. Mendenhall, R. Amdur, and J. Palta IMRT in the standard management of head and neck cancer: Promises and pitfalls J Clin Oncol 24 2006 2618 2623
28. P.M. Harari Beware the swing and a miss: Baseball precautions for conformal radiotherapy Int J Radiat Oncol Biol Phys 70 2008 657 659
29. W.M. Mendenhall, and A.A. Mancuso Radiotherapy for head and neck cancer - Is the "next level" down? Int J Radiat Oncol Biol Phys 73 2009 645 646
30. L.A.G. Ries, D. Melbert, and M. Krapcho SEER cancer statistics review, 1975-2004 2006 National Cancer Institute Bethesda
31. J.A. Langendijk, P. Doornaert, and I.M. Verdonck-de Leeuw Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy J Clin Oncol 26 2008 3770 3776
32. C. Nutting, R. A'Hern, M.S. Rogers PARSPORT Trial Management Group First results of a phase III multicenter randomized controlled trial of intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT) [Abstract] J Clin Oncol 27 Suppl 2009 18s
33. F.Y. Feng, H.M. Kim, and T.H. Lyden Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: Early-dose effect relationships for the swallowing structures Int J Radiat Oncol Biol Phys 68 2007 1289 1298
34. A.S. Tsao, A.S. Garden, and M.S. Kies Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck J Clin Oncol 24 2006 4163 4169
35. J.L. Lefebvre Laryngeal preservation in head and neck cancer: Multidisciplinary approach Lancet Oncol 7 2006 747 755